Literature DB >> 17878691

Nutritional treatment of a patient with hepatic cirrhosis with the novel low glycemic index liquid food (Inslow).

Dai Matsumoto1, Hisami Yamanaka-Okumura, Hidekazu Arai, Masae Sakuma, Hironori Yamamoto, Yutaka Taketani, Yoshiko Tani, Yuji Morine, Mitsuo Shimada, Eiji Takeda.   

Abstract

A sixty-six year-old patient with liver cirrhosis and diabetes was nutritionally treated by administration of the low glycemic index liquid food (Inslow) as a late evening sack (LES) for 6 weeks. The mean energy intake increased from 825+/-48 kcal/d to 1567+/-66 kcal/d after the 6-week treatment period. The fasting glucose level did not change, remaining at about 100 mg/dl throughout this period. Interestingly, the amount of insulin administered was reduced from 38 units before treatment to 28 units in the fifth week of treatment without a change in the fasting glucose level. This indicates a marked improvement in insulin sensitivity due to Inslow administration in this patient. In conclusion, the long-term administration of Inslow as an LES may be an effective treatment for cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878691     DOI: 10.2152/jmi.54.375

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  1 in total

1.  Effects of GLUT4 expression on insulin resistance in patients with advanced liver cirrhosis.

Authors:  Wei-Feng Shan; Bing-Quan Chen; Shao-Jun Zhu; Li Jiang; Yan-Feng Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.